SOLV News and Press, Solventum Corporation From 02/26/26

Solventum Corporation (SOLV) is expected to report $1.5 for Q4 2025

2026-02-22 09:05:35 ET More on State Street Health Care Select Sector SPDR ETF VT: Still The Best Approach To Passive Investing Market Sector Review: Extreme Market Bifurcation Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More ...

Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 PR Newswire ST. PAUL, Minn. , Feb. 3, 2026 /PRNewswire/ -- Solventum  (NYSE: SOLV) will release its fourth quarter fiscal 2025 financial results on Thursday, Feb. 26, 2026 , afte...

2026-02-02 20:49:20 ET This article is part of a series that provides an ongoing analysis of the changes made to Davis Selected Advisers’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/02/2026. Please visit our Tracking Christopher ...

2026-02-02 06:56:54 ET More on SOLV Energy, LLC Solar EPC Provider SOLV Energy Begins IPO Effort Seeking Alpha’s Quant Rating on SOLV Energy, LLC Financial information for SOLV Energy, LLC Read the full article on Seeking Alpha For further deta...

2026-01-26 13:24:11 ET More on Solventum Corporation Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Solventum: Setting Up For Growth And A Re-Rating ...

2026-01-25 22:50:09 ET Brett Fishbin from KeyBanc issued a price target of $97.00 for SOLV on 2026-01-26 01:51:33. The adjusted price target was set to $97.00. At the time of the announcement, SOLV was trading at $78.91. The overall price target consensus is at $95.80 wi...

2026-01-18 13:01:43 ET More on SPDR S&P 500 ETF Trust Treasury Rates May Be About To Break Out Climbing A Wall Of Misery Inflation: Falling...But.... Catalyst Watch: Intel earnings, drama in Davos, and the fight for Warner Bros. Market Voices: Tru...

2026-01-18 09:05:59 ET More on The Health Care Select Sector SPDR® Fund ETF XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins? Where To Find Outperformance In 2026 My S&P 500 Prediction On Sector Outperformers And Laggards In 2026 M...

2026-01-07 08:05:40 ET from Stifel Nicolaus issued a price target of $105.00 for SOLV on 2026-01-07 12:35:13. The adjusted price target was set to $105.00. At the time of the announcement, SOLV was trading at $83.16. The overall price target consensus is at $93.33 with h...